Daily Physical Activity, Fasting Glucose, Uric Acid, and Body Mass Index Are Independent Factors Associated With Serum Fibroblast Growth Factor 21 Levels

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-10-0454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Body Mass Index and Daily Physical Activity in Anorexia Nervosa

Medicine and Science in Sports and Exercise
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
1996English

Serum Level of Fibroblast Growth Factor 21 Is Independently Associated With Acute Myocardial Infarction

PLoS ONE
Multidisciplinary
2015English

Serum Uric Acid and Plasma Glucose Levels in Normal Pregnancy

American Journal of Laboratory Medicine
2019English

Whole-Body Insulin Sensitivity Rather Than Body-Mass-Index Determines Fasting and Post-Glucose-Load Growth Hormone Concentrations

PLoS ONE
Multidisciplinary
2014English

Correlation of Altered Lipid Profile, Uric Acid and Fasting Plasma Glucose Levels in Females With Hypothyroidism

Endocrinology & Metabolic Syndrome
2017English

Elevated Serum Uric Acid Levels Are Associated With Increased Risk Score and Mace Development in Patients With Stemi

Annals of Medical Research
2019English

The Association Between Serum Growth Differentiation Factor 15 Levels and Lower Extremity Atherosclerotic Disease Is Independent of Body Mass Index in Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2020English

Variants of ADRA2A Are Associated With Fasting Glucose, Blood Pressure, Body Mass Index and Type 2 Diabetes Risk: Meta-Analysis of Four Prospective Studies

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy